05:12 PM EST, 11/13/2024 (MT Newswires) -- ScPharmaceuticals ( SCPH ) reported a Q3 loss late Wednesday of $0.75 per diluted share, widening from the $0.41 loss a year earlier.

Analysts polled by Capital IQ expected a loss of $0.30.

Revenue in the three months ended Sept. 30 rose to $10 million from $3.8 million a year earlier, scPharmaceuticals said.

Analysts surveyed by Capital IQ expected $10.8 million.

Price: 3.81, Change: -0.10, Percent Change: -2.56